Relatlimab: a novel drug targeting immune checkpoint LAG-3 in melanoma therapy

ABSTRACT:

SUBMITTER: Su J 

PROVIDER: S-EPMC10806167 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature